MX2007007145A - Lineas de celulas para produccion de adenovirus con replicacion defectuosa. - Google Patents

Info

Publication number

MX2007007145A

MX2007007145A MX2007007145A MX2007007145A MX2007007145A MX 2007007145 A MX2007007145 A MX 2007007145A MX 2007007145 A MX2007007145 A MX 2007007145A MX 2007007145 A MX2007007145 A MX 2007007145A MX 2007007145 A MX2007007145 A MX 2007007145A

Authority

MX

Mexico

Prior art keywords

protein

nucleic acid

cell line

adenoviral

nucleotide sequence

Prior art date

2004-12-13

Links

• Espacenet
• Global Dossier
• Discuss

• 241000701161 unidentified adenovirus Species 0.000 title claims abstract description 325
• 238000004519 manufacturing process Methods 0.000 title claims abstract description 121
• 108090000623 proteins and genes Proteins 0.000 claims abstract description 590
• 102000004169 proteins and genes Human genes 0.000 claims abstract description 477
• 239000013598 vector Substances 0.000 claims abstract description 107
• 230000010076 replication Effects 0.000 claims abstract description 83
• 210000004027 cell Anatomy 0.000 claims description 655
• 150000007523 nucleic acids Chemical class 0.000 claims description 286
• 239000002773 nucleotide Substances 0.000 claims description 203
• 125000003729 nucleotide group Chemical group 0.000 claims description 203
• 125000000539 amino acid group Chemical group 0.000 claims description 191
• 230000014509 gene expression Effects 0.000 claims description 183
• 102000039446 nucleic acids Human genes 0.000 claims description 171
• 108020004707 nucleic acids Proteins 0.000 claims description 171
• 241000700605 Viruses Species 0.000 claims description 146
• 238000000034 method Methods 0.000 claims description 118
• 230000002950 deficient Effects 0.000 claims description 101
• 238000012217 deletion Methods 0.000 claims description 101
• 101710199711 Early E1A protein Proteins 0.000 claims description 100
• 230000037430 deletion Effects 0.000 claims description 99
• 210000005260 human cell Anatomy 0.000 claims description 83
• 230000003612 virological effect Effects 0.000 claims description 83
• 230000027455 binding Effects 0.000 claims description 76
• 101000882390 Homo sapiens Histone acetyltransferase p300 Proteins 0.000 claims description 75
• 102100038885 Histone acetyltransferase p300 Human genes 0.000 claims description 74
• 101000978776 Mus musculus Neurogenic locus notch homolog protein 1 Proteins 0.000 claims description 74
• 239000013612 plasmid Substances 0.000 claims description 68
• 101710124357 Retinoblastoma-associated protein Proteins 0.000 claims description 55
• 102100038042 Retinoblastoma-associated protein Human genes 0.000 claims description 55
• 150000001413 amino acids Chemical class 0.000 claims description 41
• 230000001105 regulatory effect Effects 0.000 claims description 26
• 238000012258 culturing Methods 0.000 claims description 15
• 230000001131 transforming effect Effects 0.000 claims description 11
• 101000765604 Bacillus subtilis (strain 168) FlaA locus 22.9 kDa protein Proteins 0.000 claims description 10
• 101000964402 Caldicellulosiruptor saccharolyticus Uncharacterized protein in xynC 3'region Proteins 0.000 claims description 10
• 101000977779 Lymantria dispar multicapsid nuclear polyhedrosis virus Uncharacterized 33.9 kDa protein in PE 3'region Proteins 0.000 claims description 10
• 101000827630 Narcissus mosaic virus Uncharacterized 10 kDa protein Proteins 0.000 claims description 10
• 239000002253 acid Substances 0.000 claims description 9
• 238000003306 harvesting Methods 0.000 claims description 8
• 101150032643 IVa2 gene Proteins 0.000 claims description 7
• 101000787132 Acidithiobacillus ferridurans Uncharacterized 8.2 kDa protein in mobL 3'region Proteins 0.000 claims description 5
• 101000827262 Acidithiobacillus ferrooxidans Uncharacterized 18.9 kDa protein in mobE 3'region Proteins 0.000 claims description 5
• 101000811747 Antithamnion sp. UPF0051 protein in atpA 3'region Proteins 0.000 claims description 5
• 101000827607 Bacillus phage SPP1 Uncharacterized 8.5 kDa protein in GP2-GP6 intergenic region Proteins 0.000 claims description 5
• 101000961975 Bacillus thuringiensis Uncharacterized 13.4 kDa protein Proteins 0.000 claims description 5
• 101000964407 Caldicellulosiruptor saccharolyticus Uncharacterized 10.7 kDa protein in xynB 3'region Proteins 0.000 claims description 5
• 102000052510 DNA-Binding Proteins Human genes 0.000 claims description 5
• 101710096438 DNA-binding protein Proteins 0.000 claims description 5
• 101150066038 E4 gene Proteins 0.000 claims description 5
• 101000768777 Haloferax lucentense (strain DSM 14919 / JCM 9276 / NCIMB 13854 / Aa 2.2) Uncharacterized 50.6 kDa protein in the 5'region of gyrA and gyrB Proteins 0.000 claims description 5
• 101000607404 Infectious laryngotracheitis virus (strain Thorne V882) Protein UL24 homolog Proteins 0.000 claims description 5
• 101000735632 Klebsiella pneumoniae Uncharacterized 8.8 kDa protein in aacA4 3'region Proteins 0.000 claims description 5
• 101000818100 Spirochaeta aurantia Uncharacterized 12.7 kDa protein in trpE 5'region Proteins 0.000 claims description 5
• 101001037658 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) Glucokinase Proteins 0.000 claims description 5
• 101710185720 Putative ethidium bromide resistance protein Proteins 0.000 claims description 4
• 210000004905 finger nail Anatomy 0.000 claims 1
• 230000000295 complement effect Effects 0.000 abstract description 59
• 230000006870 function Effects 0.000 abstract description 37
• 230000035772 mutation Effects 0.000 abstract description 20
• 101710114676 E1B 55 kDa protein Proteins 0.000 abstract description 6
• 238000003780 insertion Methods 0.000 abstract description 5
• 230000037431 insertion Effects 0.000 abstract description 5
• 108091028043 Nucleic acid sequence Proteins 0.000 description 106
• 108091026890 Coding region Proteins 0.000 description 72
• 208000015181 infectious disease Diseases 0.000 description 49
• 239000002245 particle Substances 0.000 description 49
• 241000282414 Homo sapiens Species 0.000 description 34
• 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 26
• 239000002609 medium Substances 0.000 description 23
• RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 22
• 239000000427 antigen Substances 0.000 description 21
• 108091007433 antigens Proteins 0.000 description 21
• 102000036639 antigens Human genes 0.000 description 21
• 239000000047 product Substances 0.000 description 21
• 239000000203 mixture Substances 0.000 description 20
• 238000013518 transcription Methods 0.000 description 19
• 230000035897 transcription Effects 0.000 description 19
• 108020004414 DNA Proteins 0.000 description 18
• 230000006907 apoptotic process Effects 0.000 description 18
• 238000004458 analytical method Methods 0.000 description 17
• 238000012360 testing method Methods 0.000 description 17
• 241000598171 Human adenovirus sp. Species 0.000 description 16
• 108090000765 processed proteins & peptides Proteins 0.000 description 15
• 230000000644 propagated effect Effects 0.000 description 15
• 238000001890 transfection Methods 0.000 description 15
• 210000004881 tumor cell Anatomy 0.000 description 15
• 241000701242 Adenoviridae Species 0.000 description 14
• YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 14
• 108700010877 adenoviridae proteins Proteins 0.000 description 14
• 238000010790 dilution Methods 0.000 description 14
• 239000012895 dilution Substances 0.000 description 14
• 230000000694 effects Effects 0.000 description 14
• 238000001415 gene therapy Methods 0.000 description 14
• 238000001262 western blot Methods 0.000 description 14
• 241001135569 Human adenovirus 5 Species 0.000 description 13
• 108020005202 Viral DNA Proteins 0.000 description 13
• 230000012010 growth Effects 0.000 description 13
• 230000036961 partial effect Effects 0.000 description 13
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 12
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 12
• 230000001413 cellular effect Effects 0.000 description 12
• 239000012091 fetal bovine serum Substances 0.000 description 12
• BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Natural products O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 12
• 239000005090 green fluorescent protein Substances 0.000 description 12
• 210000001519 tissue Anatomy 0.000 description 12
• 206010028980 Neoplasm Diseases 0.000 description 11
• 108091092356 cellular DNA Proteins 0.000 description 11
• 101150052169 cgab gene Proteins 0.000 description 11
• 239000001963 growth medium Substances 0.000 description 11
• 239000003550 marker Substances 0.000 description 11
• 229950010131 puromycin Drugs 0.000 description 11
• 238000000338 in vitro Methods 0.000 description 10
• 102000004196 processed proteins & peptides Human genes 0.000 description 10
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
• 102100037173 Mitochondrial-derived peptide MOTS-c Human genes 0.000 description 9
• 238000003556 assay Methods 0.000 description 9
• 238000004113 cell culture Methods 0.000 description 9
• 239000000499 gel Substances 0.000 description 9
• 230000001965 increasing effect Effects 0.000 description 9
• 239000000523 sample Substances 0.000 description 9
• 229930193140 Neomycin Natural products 0.000 description 8
• 239000013592 cell lysate Substances 0.000 description 8
• 238000010367 cloning Methods 0.000 description 8
• 239000003623 enhancer Substances 0.000 description 8
• 239000006166 lysate Substances 0.000 description 8
• 108020004999 messenger RNA Proteins 0.000 description 8
• 229960004927 neomycin Drugs 0.000 description 8
• 239000008194 pharmaceutical composition Substances 0.000 description 8
• 230000001902 propagating effect Effects 0.000 description 8
• 241000894007 species Species 0.000 description 8
• 210000002845 virion Anatomy 0.000 description 8
• 102000007469 Actins Human genes 0.000 description 7
• 108010085238 Actins Proteins 0.000 description 7
• 230000006820 DNA synthesis Effects 0.000 description 7
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
• 108700026244 Open Reading Frames Proteins 0.000 description 7
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
• 108700019146 Transgenes Proteins 0.000 description 7
• 239000003814 drug Substances 0.000 description 7
• 229940079593 drug Drugs 0.000 description 7
• 238000003018 immunoassay Methods 0.000 description 7
• 230000006698 induction Effects 0.000 description 7
• 230000000670 limiting effect Effects 0.000 description 7
• 239000000463 material Substances 0.000 description 7
• 230000004048 modification Effects 0.000 description 7
• 238000012986 modification Methods 0.000 description 7
• 239000012071 phase Substances 0.000 description 7
• 229920001184 polypeptide Polymers 0.000 description 7
• 238000000746 purification Methods 0.000 description 7
• 230000009466 transformation Effects 0.000 description 7
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
• 241001465754 Metazoa Species 0.000 description 6
• 238000013459 approach Methods 0.000 description 6
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
• 238000005119 centrifugation Methods 0.000 description 6
• 238000004587 chromatography analysis Methods 0.000 description 6
• 238000010276 construction Methods 0.000 description 6
• 239000013604 expression vector Substances 0.000 description 6
• 239000012634 fragment Substances 0.000 description 6
• 230000003053 immunization Effects 0.000 description 6
• 238000002649 immunization Methods 0.000 description 6
• 239000001301 oxygen Substances 0.000 description 6
• 229910052760 oxygen Inorganic materials 0.000 description 6
• 238000004806 packaging method and process Methods 0.000 description 6
• 210000000130 stem cell Anatomy 0.000 description 6
• 238000002965 ELISA Methods 0.000 description 5
• 108060001084 Luciferase Proteins 0.000 description 5
• 230000004913 activation Effects 0.000 description 5
• 239000003242 anti bacterial agent Substances 0.000 description 5
• 238000004166 bioassay Methods 0.000 description 5
• 210000004899 c-terminal region Anatomy 0.000 description 5
• 201000011510 cancer Diseases 0.000 description 5
• 238000006243 chemical reaction Methods 0.000 description 5
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 5
• 238000004440 column chromatography Methods 0.000 description 5
• 230000000120 cytopathologic effect Effects 0.000 description 5
• 238000001514 detection method Methods 0.000 description 5
• 230000029087 digestion Effects 0.000 description 5
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
• 238000009472 formulation Methods 0.000 description 5
• 238000002744 homologous recombination Methods 0.000 description 5
• 230000006801 homologous recombination Effects 0.000 description 5
• 238000011534 incubation Methods 0.000 description 5
• 230000001939 inductive effect Effects 0.000 description 5
• 230000002458 infectious effect Effects 0.000 description 5
• 238000002955 isolation Methods 0.000 description 5
• 230000002101 lytic effect Effects 0.000 description 5
• 230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 description 5
• 230000008569 process Effects 0.000 description 5
• 210000002966 serum Anatomy 0.000 description 5
• 239000003981 vehicle Substances 0.000 description 5
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
• 102100026189 Beta-galactosidase Human genes 0.000 description 4
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
• 102000004190 Enzymes Human genes 0.000 description 4
• 108090000790 Enzymes Proteins 0.000 description 4
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 4
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
• 101710125507 Integrase/recombinase Proteins 0.000 description 4
• 108700008625 Reporter Genes Proteins 0.000 description 4
• 108091027981 Response element Proteins 0.000 description 4
• -1 SEQ ID NO: 17) Proteins 0.000 description 4
• 108091023040 Transcription factor Proteins 0.000 description 4
• 102000040945 Transcription factor Human genes 0.000 description 4
• 208000036142 Viral infection Diseases 0.000 description 4
• 239000011543 agarose gel Substances 0.000 description 4
• 229940088710 antibiotic agent Drugs 0.000 description 4
• 230000001580 bacterial effect Effects 0.000 description 4
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
• 238000012512 characterization method Methods 0.000 description 4
• 238000011161 development Methods 0.000 description 4
• 230000018109 developmental process Effects 0.000 description 4
• 108020001507 fusion proteins Proteins 0.000 description 4
• 102000037865 fusion proteins Human genes 0.000 description 4
• 238000001727 in vivo Methods 0.000 description 4
• 230000006882 induction of apoptosis Effects 0.000 description 4
• 239000007788 liquid Substances 0.000 description 4
• 210000004379 membrane Anatomy 0.000 description 4
• 239000012528 membrane Substances 0.000 description 4
• 230000037361 pathway Effects 0.000 description 4
• 230000008488 polyadenylation Effects 0.000 description 4
• 238000012545 processing Methods 0.000 description 4
• 230000009467 reduction Effects 0.000 description 4
• 108091008146 restriction endonucleases Proteins 0.000 description 4
• 238000012552 review Methods 0.000 description 4
• 239000011780 sodium chloride Substances 0.000 description 4
• 238000010561 standard procedure Methods 0.000 description 4
• 230000000638 stimulation Effects 0.000 description 4
• 238000003756 stirring Methods 0.000 description 4
• 231100000419 toxicity Toxicity 0.000 description 4
• 230000001988 toxicity Effects 0.000 description 4
• 238000013519 translation Methods 0.000 description 4
• 241001515965 unidentified phage Species 0.000 description 4
• 230000009385 viral infection Effects 0.000 description 4
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 3
• 229920002307 Dextran Polymers 0.000 description 3
• 102000008857 Ferritin Human genes 0.000 description 3
• 108050000784 Ferritin Proteins 0.000 description 3
• 238000008416 Ferritin Methods 0.000 description 3
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
• 241000233866 Fungi Species 0.000 description 3
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 3
• 241000701024 Human betaherpesvirus 5 Species 0.000 description 3
• 108010050904 Interferons Proteins 0.000 description 3
• 102000014150 Interferons Human genes 0.000 description 3
• 108091029795 Intergenic region Proteins 0.000 description 3
• 108010063738 Interleukins Proteins 0.000 description 3
• 102000015696 Interleukins Human genes 0.000 description 3
• 108010021466 Mutant Proteins Proteins 0.000 description 3
• 102000008300 Mutant Proteins Human genes 0.000 description 3
• 108700020796 Oncogene Proteins 0.000 description 3
• 108020004511 Recombinant DNA Proteins 0.000 description 3
• 108020004440 Thymidine kinase Proteins 0.000 description 3
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 3
• 229960000723 ampicillin Drugs 0.000 description 3
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
• 210000004102 animal cell Anatomy 0.000 description 3
• 238000010171 animal model Methods 0.000 description 3
• 230000000890 antigenic effect Effects 0.000 description 3
• 108010005774 beta-Galactosidase Proteins 0.000 description 3
• 230000015556 catabolic process Effects 0.000 description 3
• 239000003153 chemical reaction reagent Substances 0.000 description 3
• 238000013270 controlled release Methods 0.000 description 3
• 238000007796 conventional method Methods 0.000 description 3
• 239000002577 cryoprotective agent Substances 0.000 description 3
• 230000009089 cytolysis Effects 0.000 description 3
• 230000007812 deficiency Effects 0.000 description 3
• 230000001419 dependent effect Effects 0.000 description 3
• 208000035475 disorder Diseases 0.000 description 3
• 238000004520 electroporation Methods 0.000 description 3
• 239000000835 fiber Substances 0.000 description 3
• 210000002950 fibroblast Anatomy 0.000 description 3
• 238000000684 flow cytometry Methods 0.000 description 3
• 239000008103 glucose Substances 0.000 description 3
• 230000028993 immune response Effects 0.000 description 3
• 238000001114 immunoprecipitation Methods 0.000 description 3
• 238000009169 immunotherapy Methods 0.000 description 3
• 238000002347 injection Methods 0.000 description 3
• 239000007924 injection Substances 0.000 description 3
• 229940079322 interferon Drugs 0.000 description 3
• 210000004072 lung Anatomy 0.000 description 3
• 210000004962 mammalian cell Anatomy 0.000 description 3
• 230000001404 mediated effect Effects 0.000 description 3
• 238000000520 microinjection Methods 0.000 description 3
• 238000007899 nucleic acid hybridization Methods 0.000 description 3
• 244000045947 parasite Species 0.000 description 3
• 244000052769 pathogen Species 0.000 description 3
• 230000001717 pathogenic effect Effects 0.000 description 3
• 239000000546 pharmaceutical excipient Substances 0.000 description 3
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
• 230000002829 reductive effect Effects 0.000 description 3
• 230000004044 response Effects 0.000 description 3
• 230000035945 sensitivity Effects 0.000 description 3
• 239000000243 solution Substances 0.000 description 3
• 239000003381 stabilizer Substances 0.000 description 3
• 238000003860 storage Methods 0.000 description 3
• 238000001356 surgical procedure Methods 0.000 description 3
• 230000002103 transcriptional effect Effects 0.000 description 3
• 238000012546 transfer Methods 0.000 description 3
• 102000003298 tumor necrosis factor receptor Human genes 0.000 description 3
• 229960005486 vaccine Drugs 0.000 description 3
• 230000029812 viral genome replication Effects 0.000 description 3
• VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
• 101000768957 Acholeplasma phage L2 Uncharacterized 37.2 kDa protein Proteins 0.000 description 2
• 101000823746 Acidianus ambivalens Uncharacterized 17.7 kDa protein in bps2 3'region Proteins 0.000 description 2
• 101000916369 Acidianus ambivalens Uncharacterized protein in sor 5'region Proteins 0.000 description 2
• 101000769342 Acinetobacter guillouiae Uncharacterized protein in rpoN-murA intergenic region Proteins 0.000 description 2
• 101000823696 Actinobacillus pleuropneumoniae Uncharacterized glycosyltransferase in aroQ 3'region Proteins 0.000 description 2
• 208000010370 Adenoviridae Infections Diseases 0.000 description 2
• 108010024878 Adenovirus E1A Proteins Proteins 0.000 description 2
• 206010060931 Adenovirus infection Diseases 0.000 description 2
• 101000786513 Agrobacterium tumefaciens (strain 15955) Uncharacterized protein outside the virF region Proteins 0.000 description 2
• 101000618005 Alkalihalobacillus pseudofirmus (strain ATCC BAA-2126 / JCM 17055 / OF4) Uncharacterized protein BpOF4_00885 Proteins 0.000 description 2
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
• 102100020724 Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Human genes 0.000 description 2
• 101000967489 Azorhizobium caulinodans (strain ATCC 43989 / DSM 5975 / JCM 20966 / LMG 6465 / NBRC 14845 / NCIMB 13405 / ORS 571) Uncharacterized protein AZC_3924 Proteins 0.000 description 2
• 101000823761 Bacillus licheniformis Uncharacterized 9.4 kDa protein in flaL 3'region Proteins 0.000 description 2
• 101000819719 Bacillus methanolicus Uncharacterized N-acetyltransferase in lysA 3'region Proteins 0.000 description 2
• 101000789586 Bacillus subtilis (strain 168) UPF0702 transmembrane protein YkjA Proteins 0.000 description 2
• 101000792624 Bacillus subtilis (strain 168) Uncharacterized protein YbxH Proteins 0.000 description 2
• 101000790792 Bacillus subtilis (strain 168) Uncharacterized protein YckC Proteins 0.000 description 2
• 101000819705 Bacillus subtilis (strain 168) Uncharacterized protein YlxR Proteins 0.000 description 2
• 101000948218 Bacillus subtilis (strain 168) Uncharacterized protein YtxJ Proteins 0.000 description 2
• 101000718627 Bacillus thuringiensis subsp. kurstaki Putative RNA polymerase sigma-G factor Proteins 0.000 description 2
• 241000894006 Bacteria Species 0.000 description 2
• 101000641200 Bombyx mori densovirus Putative non-structural protein Proteins 0.000 description 2
• 238000009010 Bradford assay Methods 0.000 description 2
• 229940086569 Calpain 1 inhibitor Drugs 0.000 description 2
• 241000283707 Capra Species 0.000 description 2
• 102000014914 Carrier Proteins Human genes 0.000 description 2
• 101000947633 Claviceps purpurea Uncharacterized 13.8 kDa protein Proteins 0.000 description 2
• 108020004705 Codon Proteins 0.000 description 2
• 241000711573 Coronaviridae Species 0.000 description 2
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
• 108010053770 Deoxyribonucleases Proteins 0.000 description 2
• 102000016911 Deoxyribonucleases Human genes 0.000 description 2
• 241000243234 Encephalitozoon Species 0.000 description 2
• 101000948901 Enterobacteria phage T4 Uncharacterized 16.0 kDa protein in segB-ipI intergenic region Proteins 0.000 description 2
• 241000709661 Enterovirus Species 0.000 description 2
• 101000805958 Equine herpesvirus 4 (strain 1942) Virion protein US10 homolog Proteins 0.000 description 2
• 102000003951 Erythropoietin Human genes 0.000 description 2
• 108090000394 Erythropoietin Proteins 0.000 description 2
• 241000588724 Escherichia coli Species 0.000 description 2
• 101000790442 Escherichia coli Insertion element IS2 uncharacterized 11.1 kDa protein Proteins 0.000 description 2
• 101000788354 Escherichia phage P2 Uncharacterized 8.2 kDa protein in gpA 5'region Proteins 0.000 description 2
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
• 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 2
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
• 241000711950 Filoviridae Species 0.000 description 2
• 101000770304 Frankia alni UPF0460 protein in nifX-nifW intergenic region Proteins 0.000 description 2
• 108091006027 G proteins Proteins 0.000 description 2
• 102000030782 GTP binding Human genes 0.000 description 2
• 108091000058 GTP-Binding Proteins 0.000 description 2
• 101000797344 Geobacillus stearothermophilus Putative tRNA (cytidine(34)-2'-O)-methyltransferase Proteins 0.000 description 2
• 101000748410 Geobacillus stearothermophilus Uncharacterized protein in fumA 3'region Proteins 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• 108090000288 Glycoproteins Proteins 0.000 description 2
• 102000003886 Glycoproteins Human genes 0.000 description 2
• 101000772675 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) UPF0438 protein HI_0847 Proteins 0.000 description 2
• 101000631019 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Uncharacterized protein HI_0350 Proteins 0.000 description 2
• 101000768938 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 8.9 kDa protein in int-C1 intergenic region Proteins 0.000 description 2
• 101000785414 Homo sapiens Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Proteins 0.000 description 2
• GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 description 2
• 101000782488 Junonia coenia densovirus (isolate pBRJ/1990) Putative non-structural protein NS2 Proteins 0.000 description 2
• 101000811523 Klebsiella pneumoniae Uncharacterized 55.8 kDa protein in cps region Proteins 0.000 description 2
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
• 101000818409 Lactococcus lactis subsp. lactis Uncharacterized HTH-type transcriptional regulator in lacX 3'region Proteins 0.000 description 2
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
• 101710192606 Latent membrane protein 2 Proteins 0.000 description 2
• 101000878851 Leptolyngbya boryana Putative Fe(2+) transport protein A Proteins 0.000 description 2
• 239000005089 Luciferase Substances 0.000 description 2
• 101000758828 Methanosarcina barkeri (strain Fusaro / DSM 804) Uncharacterized protein Mbar_A1602 Proteins 0.000 description 2
• NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 2
• 101001122401 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF3 Proteins 0.000 description 2
• 241001529936 Murinae Species 0.000 description 2
• 101001055788 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) Pentapeptide repeat protein MfpA Proteins 0.000 description 2
• 241000204031 Mycoplasma Species 0.000 description 2
• 108091092724 Noncoding DNA Proteins 0.000 description 2
• 101710087110 ORF6 protein Proteins 0.000 description 2
• 101000740670 Orgyia pseudotsugata multicapsid polyhedrosis virus Protein C42 Proteins 0.000 description 2
• 239000002033 PVDF binder Substances 0.000 description 2
• 101000769182 Photorhabdus luminescens Uncharacterized protein in pnp 3'region Proteins 0.000 description 2
• 206010035226 Plasma cell myeloma Diseases 0.000 description 2
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
• 101000961392 Pseudescherichia vulneris Uncharacterized 29.9 kDa protein in crtE 3'region Proteins 0.000 description 2
• 101000731030 Pseudomonas oleovorans Poly(3-hydroxyalkanoate) polymerase 2 Proteins 0.000 description 2
• 101001065485 Pseudomonas putida Probable fatty acid methyltransferase Proteins 0.000 description 2
• 101000711023 Rhizobium leguminosarum bv. trifolii Uncharacterized protein in tfuA 3'region Proteins 0.000 description 2
• 101000948156 Rhodococcus erythropolis Uncharacterized 47.3 kDa protein in thcA 5'region Proteins 0.000 description 2
• 101000917565 Rhodococcus fascians Uncharacterized 33.6 kDa protein in fasciation locus Proteins 0.000 description 2
• 108010083644 Ribonucleases Proteins 0.000 description 2
• 102000006382 Ribonucleases Human genes 0.000 description 2
• 241000710799 Rubella virus Species 0.000 description 2
• 101000790284 Saimiriine herpesvirus 2 (strain 488) Uncharacterized 9.5 kDa protein in DHFR 3'region Proteins 0.000 description 2
• 229920002684 Sepharose Polymers 0.000 description 2
• 102100026900 Signal recognition particle receptor subunit alpha Human genes 0.000 description 2
• 101710126382 Signal recognition particle receptor subunit alpha Proteins 0.000 description 2
• 101710111458 Signal recognition particle receptor subunit alpha homolog Proteins 0.000 description 2
• 229920002472 Starch Polymers 0.000 description 2
• 101000936719 Streptococcus gordonii Accessory Sec system protein Asp3 Proteins 0.000 description 2
• 101000788499 Streptomyces coelicolor Uncharacterized oxidoreductase in mprA 5'region Proteins 0.000 description 2
• 101001102841 Streptomyces griseus Purine nucleoside phosphorylase ORF3 Proteins 0.000 description 2
• 101000708557 Streptomyces lincolnensis Uncharacterized 17.2 kDa protein in melC2-rnhH intergenic region Proteins 0.000 description 2
• 210000001744 T-lymphocyte Anatomy 0.000 description 2
• 108700026226 TATA Box Proteins 0.000 description 2
• 101710109576 Terminal protein Proteins 0.000 description 2
• 101000649826 Thermotoga neapolitana Putative anti-sigma factor antagonist TM1081 homolog Proteins 0.000 description 2
• 102100031294 Thymic stromal lymphopoietin Human genes 0.000 description 2
• 102000006601 Thymidine Kinase Human genes 0.000 description 2
• 239000007983 Tris buffer Substances 0.000 description 2
• 101710095001 Uncharacterized protein in nifU 5'region Proteins 0.000 description 2
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
• 101000827562 Vibrio alginolyticus Uncharacterized protein in proC 3'region Proteins 0.000 description 2
• 101000778915 Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) Uncharacterized membrane protein VP2115 Proteins 0.000 description 2
• 108700005077 Viral Genes Proteins 0.000 description 2
• 108010067390 Viral Proteins Proteins 0.000 description 2
• 150000007513 acids Chemical class 0.000 description 2
• 208000011589 adenoviridae infectious disease Diseases 0.000 description 2
• 238000013019 agitation Methods 0.000 description 2
• 239000013566 allergen Substances 0.000 description 2
• UPEZCKBFRMILAV-UHFFFAOYSA-N alpha-Ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C(O)CCC(C)(C)O)C)CCC33O)C)C3=CC(=O)C21 UPEZCKBFRMILAV-UHFFFAOYSA-N 0.000 description 2
• 230000004075 alteration Effects 0.000 description 2
• 230000003698 anagen phase Effects 0.000 description 2
• 238000005571 anion exchange chromatography Methods 0.000 description 2
• 230000001640 apoptogenic effect Effects 0.000 description 2
• 108091008324 binding proteins Proteins 0.000 description 2
• 230000008512 biological response Effects 0.000 description 2
• 230000015572 biosynthetic process Effects 0.000 description 2
• 238000001815 biotherapy Methods 0.000 description 2
• OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 2
• 210000000601 blood cell Anatomy 0.000 description 2
• 239000001506 calcium phosphate Substances 0.000 description 2
• 229910000389 calcium phosphate Inorganic materials 0.000 description 2
• 235000011010 calcium phosphates Nutrition 0.000 description 2
• 108010079785 calpain inhibitors Proteins 0.000 description 2
• 239000006143 cell culture medium Substances 0.000 description 2
• 230000022131 cell cycle Effects 0.000 description 2
• 230000006369 cell cycle progression Effects 0.000 description 2
• 230000008859 change Effects 0.000 description 2
• 210000000349 chromosome Anatomy 0.000 description 2
• 239000012141 concentrate Substances 0.000 description 2
• YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 2
• 210000000805 cytoplasm Anatomy 0.000 description 2
• 230000034994 death Effects 0.000 description 2
• 238000006731 degradation reaction Methods 0.000 description 2
• 238000001085 differential centrifugation Methods 0.000 description 2
• 201000010099 disease Diseases 0.000 description 2
• 239000003937 drug carrier Substances 0.000 description 2
• 210000002919 epithelial cell Anatomy 0.000 description 2
• 229940105423 erythropoietin Drugs 0.000 description 2
• 230000005284 excitation Effects 0.000 description 2
• 238000000605 extraction Methods 0.000 description 2
• 230000008014 freezing Effects 0.000 description 2
• 238000007710 freezing Methods 0.000 description 2
• 239000011521 glass Substances 0.000 description 2
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
• 230000013595 glycosylation Effects 0.000 description 2
• 238000006206 glycosylation reaction Methods 0.000 description 2
• 239000003102 growth factor Substances 0.000 description 2
• 238000004128 high performance liquid chromatography Methods 0.000 description 2
• 229940088597 hormone Drugs 0.000 description 2
• 239000005556 hormone Substances 0.000 description 2
• GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 description 2
• 229940097277 hygromycin b Drugs 0.000 description 2
• 239000007943 implant Substances 0.000 description 2
• 230000001976 improved effect Effects 0.000 description 2
• 238000001802 infusion Methods 0.000 description 2
• 239000003999 initiator Substances 0.000 description 2
• 230000010354 integration Effects 0.000 description 2
• 238000007918 intramuscular administration Methods 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 239000008101 lactose Substances 0.000 description 2
• 208000032839 leukemia Diseases 0.000 description 2
• 238000001638 lipofection Methods 0.000 description 2
• 210000004185 liver Anatomy 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 244000005700 microbiome Species 0.000 description 2
• 239000003607 modifier Substances 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 238000012544 monitoring process Methods 0.000 description 2
• 210000000214 mouth Anatomy 0.000 description 2
• 229910052757 nitrogen Inorganic materials 0.000 description 2
• 210000004940 nucleus Anatomy 0.000 description 2
• 238000005457 optimization Methods 0.000 description 2
• 238000006213 oxygenation reaction Methods 0.000 description 2
• 230000010412 perfusion Effects 0.000 description 2
• 238000011170 pharmaceutical development Methods 0.000 description 2
• 230000004962 physiological condition Effects 0.000 description 2
• 108091033319 polynucleotide Proteins 0.000 description 2
• 102000040430 polynucleotide Human genes 0.000 description 2
• 239000002157 polynucleotide Substances 0.000 description 2
• 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 2
• 238000001556 precipitation Methods 0.000 description 2
• 238000011002 quantification Methods 0.000 description 2
• 230000006798 recombination Effects 0.000 description 2
• 238000005215 recombination Methods 0.000 description 2
• 230000003362 replicative effect Effects 0.000 description 2
• 230000000241 respiratory effect Effects 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• 238000005096 rolling process Methods 0.000 description 2
• 238000012163 sequencing technique Methods 0.000 description 2
• DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
• 230000010473 stable expression Effects 0.000 description 2
• 229910001220 stainless steel Inorganic materials 0.000 description 2
• 239000010935 stainless steel Substances 0.000 description 2
• 239000008107 starch Substances 0.000 description 2
• 235000019698 starch Nutrition 0.000 description 2
• 238000007920 subcutaneous administration Methods 0.000 description 2
• 239000000829 suppository Substances 0.000 description 2
• 239000000725 suspension Substances 0.000 description 2
• 238000004114 suspension culture Methods 0.000 description 2
• 230000009885 systemic effect Effects 0.000 description 2
• 239000003826 tablet Substances 0.000 description 2
• 108010029307 thymic stromal lymphopoietin Proteins 0.000 description 2
• 238000010361 transduction Methods 0.000 description 2
• 230000026683 transduction Effects 0.000 description 2
• 238000003146 transient transfection Methods 0.000 description 2
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
• 239000013603 viral vector Substances 0.000 description 2
• HBZBAMXERPYTFS-SECBINFHSA-N (4S)-2-(6,7-dihydro-5H-pyrrolo[3,2-f][1,3]benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-carboxylic acid Chemical compound OC(=O)[C@H]1CSC(=N1)c1nc2cc3CCNc3cc2s1 HBZBAMXERPYTFS-SECBINFHSA-N 0.000 description 1
• JYCQQPHGFMYQCF-UHFFFAOYSA-N 4-tert-Octylphenol monoethoxylate Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCO)C=C1 JYCQQPHGFMYQCF-UHFFFAOYSA-N 0.000 description 1
• 101150094949 APRT gene Proteins 0.000 description 1
• 101150026173 ARG2 gene Proteins 0.000 description 1
• 241000235389 Absidia Species 0.000 description 1
• 241000589291 Acinetobacter Species 0.000 description 1
• 241000186361 Actinobacteria <class> Species 0.000 description 1
• 208000026872 Addison Disease Diseases 0.000 description 1
• 108010024223 Adenine phosphoribosyltransferase Proteins 0.000 description 1
• 102100029457 Adenine phosphoribosyltransferase Human genes 0.000 description 1
• 108010087905 Adenovirus E1B Proteins Proteins 0.000 description 1
• 229920000936 Agarose Polymers 0.000 description 1
• HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 1
• 108700028369 Alleles Proteins 0.000 description 1
• 241001467448 Amblyospora Species 0.000 description 1
• 241001126715 Ameson Species 0.000 description 1
• 241000498253 Ancylostoma duodenale Species 0.000 description 1
• 241000243790 Angiostrongylus cantonensis Species 0.000 description 1
• 241000224482 Apicomplexa Species 0.000 description 1
• 241000293035 Apophysomyces Species 0.000 description 1
• 101001084702 Arabidopsis thaliana Histone H2B.10 Proteins 0.000 description 1
• 240000005528 Arctium lappa Species 0.000 description 1
• 241000712891 Arenavirus Species 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 241000244185 Ascaris lumbricoides Species 0.000 description 1
• 241000228212 Aspergillus Species 0.000 description 1
• 241000228197 Aspergillus flavus Species 0.000 description 1
• 241001225321 Aspergillus fumigatus Species 0.000 description 1
• 241000228245 Aspergillus niger Species 0.000 description 1
• 241001533362 Astroviridae Species 0.000 description 1
• 241000984758 Atoxoplasma Species 0.000 description 1
• 208000023275 Autoimmune disease Diseases 0.000 description 1
• 241000271566 Aves Species 0.000 description 1
• 241000223836 Babesia Species 0.000 description 1
• 241000223838 Babesia bovis Species 0.000 description 1
• 241001455947 Babesia divergens Species 0.000 description 1
• 241000223848 Babesia microti Species 0.000 description 1
• 241000193830 Bacillus <bacterium> Species 0.000 description 1
• 241000606125 Bacteroides Species 0.000 description 1
• 241000228405 Blastomyces dermatitidis Species 0.000 description 1
• 241000589968 Borrelia Species 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 241000589562 Brucella Species 0.000 description 1
• 241000244036 Brugia Species 0.000 description 1
• 241000589513 Burkholderia cepacia Species 0.000 description 1
• 101100505076 Caenorhabditis elegans gly-2 gene Proteins 0.000 description 1
• 241000714198 Caliciviridae Species 0.000 description 1
• 229940121926 Calpain inhibitor Drugs 0.000 description 1
• 102100035037 Calpastatin Human genes 0.000 description 1
• 241000589876 Campylobacter Species 0.000 description 1
• 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
• 241000222122 Candida albicans Species 0.000 description 1
• 241000222173 Candida parapsilosis Species 0.000 description 1
• 241000222178 Candida tropicalis Species 0.000 description 1
• 241000282465 Canis Species 0.000 description 1
• 241000710190 Cardiovirus Species 0.000 description 1
• 102000011727 Caspases Human genes 0.000 description 1
• 108010076667 Caspases Proteins 0.000 description 1
• 241000606161 Chlamydia Species 0.000 description 1
• 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
• 241000724565 Chorella virus Species 0.000 description 1
• 241000588923 Citrobacter Species 0.000 description 1
• 241000193403 Clostridium Species 0.000 description 1
• 241000223205 Coccidioides immitis Species 0.000 description 1
• 241000702669 Coltivirus Species 0.000 description 1
• 108091035707 Consensus sequence Proteins 0.000 description 1
• 241000557626 Corvus corax Species 0.000 description 1
• 241000186216 Corynebacterium Species 0.000 description 1
• 241001445332 Coxiella <snail> Species 0.000 description 1
• 241000150230 Crimean-Congo hemorrhagic fever orthonairovirus Species 0.000 description 1
• 201000007336 Cryptococcosis Diseases 0.000 description 1
• 241000221204 Cryptococcus neoformans Species 0.000 description 1
• 241000223936 Cryptosporidium parvum Species 0.000 description 1
• 201000003808 Cystic echinococcosis Diseases 0.000 description 1
• 241000987822 Cystoisospora Species 0.000 description 1
• 241000205707 Cystoisospora belli Species 0.000 description 1
• 102000004127 Cytokines Human genes 0.000 description 1
• 108090000695 Cytokines Proteins 0.000 description 1
• 241000701022 Cytomegalovirus Species 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• 101150074155 DHFR gene Proteins 0.000 description 1
• 102000053602 DNA Human genes 0.000 description 1
• 230000004544 DNA amplification Effects 0.000 description 1
• 230000004543 DNA replication Effects 0.000 description 1
• 238000001712 DNA sequencing Methods 0.000 description 1
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
• 241001533413 Deltavirus Species 0.000 description 1
• 241000702421 Dependoparvovirus Species 0.000 description 1
• 241000202828 Dermatobia hominis Species 0.000 description 1
• 241000157306 Dientamoeba fragilis Species 0.000 description 1
• 241000866683 Diphyllobothrium latum Species 0.000 description 1
• 101150013359 E7 gene Proteins 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
• 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 1
• 241000244170 Echinococcus granulosus Species 0.000 description 1
• 241000244163 Echinococcus multilocularis Species 0.000 description 1
• 241000605314 Ehrlichia Species 0.000 description 1
• 241000223924 Eimeria Species 0.000 description 1
• 206010014596 Encephalitis Japanese B Diseases 0.000 description 1
• 241000710188 Encephalomyocarditis virus Species 0.000 description 1
• 108010067770 Endopeptidase K Proteins 0.000 description 1
• 241000224432 Entamoeba histolytica Species 0.000 description 1
• 241000588914 Enterobacter Species 0.000 description 1
• 241000498256 Enterobius Species 0.000 description 1
• 241000194033 Enterococcus Species 0.000 description 1
• 241001126836 Enterocytozoon Species 0.000 description 1
• 241000710803 Equine arteritis virus Species 0.000 description 1
• 241000283073 Equus caballus Species 0.000 description 1
• 241000186811 Erysipelothrix Species 0.000 description 1
• 241000588722 Escherichia Species 0.000 description 1
• 241000495778 Escherichia faecalis Species 0.000 description 1
• 241000242711 Fasciola hepatica Species 0.000 description 1
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
• 241000702658 Fijivirus Species 0.000 description 1
• 241000710781 Flaviviridae Species 0.000 description 1
• 241000710831 Flavivirus Species 0.000 description 1
• 208000014770 Foot disease Diseases 0.000 description 1
• 241000897260 Frenkelia Species 0.000 description 1
• 101150066002 GFP gene Proteins 0.000 description 1
• 108010001515 Galectin 4 Proteins 0.000 description 1
• 102100039556 Galectin-4 Human genes 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 208000031448 Genomic Instability Diseases 0.000 description 1
• 241000224467 Giardia intestinalis Species 0.000 description 1
• 108010060309 Glucuronidase Proteins 0.000 description 1
• 102000053187 Glucuronidase Human genes 0.000 description 1
• 241001508494 Glugea Species 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
• 241001490754 Gregarina Species 0.000 description 1
• 102000009465 Growth Factor Receptors Human genes 0.000 description 1
• 108010009202 Growth Factor Receptors Proteins 0.000 description 1
• 241000606790 Haemophilus Species 0.000 description 1
• 241001301839 Haemoproteus Species 0.000 description 1
• 241000406101 Hammondia Species 0.000 description 1
• 241001442373 Haplosporidium Species 0.000 description 1
• 241000589989 Helicobacter Species 0.000 description 1
• 241000711549 Hepacivirus C Species 0.000 description 1
• 241000700739 Hepadnaviridae Species 0.000 description 1
• 241000700721 Hepatitis B virus Species 0.000 description 1
• 241000709715 Hepatovirus Species 0.000 description 1
• 241000700586 Herpesviridae Species 0.000 description 1
• 241000238631 Hexapoda Species 0.000 description 1
• 241000228404 Histoplasma capsulatum Species 0.000 description 1
• 208000017604 Hodgkin disease Diseases 0.000 description 1
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 101000742859 Homo sapiens Retinoblastoma-associated protein Proteins 0.000 description 1
• 101000597779 Homo sapiens Tumor necrosis factor ligand superfamily member 18 Proteins 0.000 description 1
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
• 241000598436 Human T-cell lymphotropic virus Species 0.000 description 1
• 241000701109 Human adenovirus 2 Species 0.000 description 1
• 241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
• 241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
• 241001243761 Human hepatitis A virus Species 0.000 description 1
• 241000701027 Human herpesvirus 6 Species 0.000 description 1
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
• 241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
• 241000701806 Human papillomavirus Species 0.000 description 1
• 241000709701 Human poliovirus 1 Species 0.000 description 1
• 241000726041 Human respirovirus 1 Species 0.000 description 1
• 241001464384 Hymenolepis nana Species 0.000 description 1
• XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 108060003951 Immunoglobulin Proteins 0.000 description 1
• 102000012745 Immunoglobulin Subunits Human genes 0.000 description 1
• 108010079585 Immunoglobulin Subunits Proteins 0.000 description 1
• 102100026720 Interferon beta Human genes 0.000 description 1
• 108090000467 Interferon-beta Proteins 0.000 description 1
• 108090000174 Interleukin-10 Proteins 0.000 description 1
• 108010065805 Interleukin-12 Proteins 0.000 description 1
• 108090000172 Interleukin-15 Proteins 0.000 description 1
• 108090000171 Interleukin-18 Proteins 0.000 description 1
• 108010002350 Interleukin-2 Proteins 0.000 description 1
• 108010065637 Interleukin-23 Proteins 0.000 description 1
• 108010002386 Interleukin-3 Proteins 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 108010002616 Interleukin-5 Proteins 0.000 description 1
• 108090001005 Interleukin-6 Proteins 0.000 description 1
• 108010002586 Interleukin-7 Proteins 0.000 description 1
• 108010002335 Interleukin-9 Proteins 0.000 description 1
• 241000555269 Ippy mammarenavirus Species 0.000 description 1
• 241000567229 Isospora Species 0.000 description 1
• 206010023076 Isosporiasis Diseases 0.000 description 1
• 201000005807 Japanese encephalitis Diseases 0.000 description 1
• 241000710842 Japanese encephalitis virus Species 0.000 description 1
• 241000588748 Klebsiella Species 0.000 description 1
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
• 241000712902 Lassa mammarenavirus Species 0.000 description 1
• 241000589248 Legionella Species 0.000 description 1
• 208000007764 Legionnaires' Disease Diseases 0.000 description 1
• 241000222738 Leishmania aethiopica Species 0.000 description 1
• 241000222727 Leishmania donovani Species 0.000 description 1
• 241000222734 Leishmania mexicana Species 0.000 description 1
• 241000713666 Lentivirus Species 0.000 description 1
• 241001470497 Leucocytozoon Species 0.000 description 1
• 241000186781 Listeria Species 0.000 description 1
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
• 208000016604 Lyme disease Diseases 0.000 description 1
• 241000712899 Lymphocytic choriomeningitis mammarenavirus Species 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 241001115401 Marburgvirus Species 0.000 description 1
• 241000701244 Mastadenovirus Species 0.000 description 1
• 102100025169 Max-binding protein MNT Human genes 0.000 description 1
• 201000005505 Measles Diseases 0.000 description 1
• 108090000157 Metallothionein Proteins 0.000 description 1
• 241000235048 Meyerozyma guilliermondii Species 0.000 description 1
• 241001295810 Microsporidium Species 0.000 description 1
• 241001480037 Microsporum Species 0.000 description 1
• 241000588621 Moraxella Species 0.000 description 1
• 241000712045 Morbillivirus Species 0.000 description 1
• 241000588771 Morganella <proteobacterium> Species 0.000 description 1
• 241000912627 Mrazekia Species 0.000 description 1
• 241000235395 Mucor Species 0.000 description 1
• 208000034578 Multiple myelomas Diseases 0.000 description 1
• 241000711386 Mumps virus Species 0.000 description 1
• 241000714177 Murine leukemia virus Species 0.000 description 1
• 241000186359 Mycobacterium Species 0.000 description 1
• 241000700562 Myxoma virus Species 0.000 description 1
• GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
• 241000498271 Necator Species 0.000 description 1
• 241000588653 Neisseria Species 0.000 description 1
• 241000588650 Neisseria meningitidis Species 0.000 description 1
• 108700019961 Neoplasm Genes Proteins 0.000 description 1
• 102000048850 Neoplasm Genes Human genes 0.000 description 1
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
• 238000000636 Northern blotting Methods 0.000 description 1
• 241001126829 Nosema Species 0.000 description 1
• 108091034117 Oligonucleotide Proteins 0.000 description 1
• 241000243985 Onchocerca volvulus Species 0.000 description 1
• 102000043276 Oncogene Human genes 0.000 description 1
• 241000242716 Opisthorchis Species 0.000 description 1
• 241000150452 Orthohantavirus Species 0.000 description 1
• 241000712464 Orthomyxoviridae Species 0.000 description 1
• 240000007594 Oryza sativa Species 0.000 description 1
• 235000007164 Oryza sativa Nutrition 0.000 description 1
• 238000010222 PCR analysis Methods 0.000 description 1
• 241001631646 Papillomaviridae Species 0.000 description 1
• 241000593811 Paracapillaria philippinensis Species 0.000 description 1
• 241000526686 Paracoccidioides brasiliensis Species 0.000 description 1
• 241000551217 Paragonimus caliensis Species 0.000 description 1
• 241001480234 Paragonimus westermani Species 0.000 description 1
• 241000711504 Paramyxoviridae Species 0.000 description 1
• 241000701945 Parvoviridae Species 0.000 description 1
• 241000606860 Pasteurella Species 0.000 description 1
• 241000606856 Pasteurella multocida Species 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 241000517307 Pediculus humanus Species 0.000 description 1
• 241001134758 Perkinsus Species 0.000 description 1
• 208000031845 Pernicious anaemia Diseases 0.000 description 1
• 241000710778 Pestivirus Species 0.000 description 1
• 240000009188 Phyllostachys vivax Species 0.000 description 1
• 241000235645 Pichia kudriavzevii Species 0.000 description 1
• 241000709664 Picornaviridae Species 0.000 description 1
• 241000224016 Plasmodium Species 0.000 description 1
• 241000223960 Plasmodium falciparum Species 0.000 description 1
• 241001505293 Plasmodium ovale Species 0.000 description 1
• 206010035502 Plasmodium ovale infection Diseases 0.000 description 1
• 241001492488 Pleistophora Species 0.000 description 1
• 241000233872 Pneumocystis carinii Species 0.000 description 1
• 241000711902 Pneumovirus Species 0.000 description 1
• 241001582367 Polia Species 0.000 description 1
• 208000000474 Poliomyelitis Diseases 0.000 description 1
• RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
• 241000700625 Poxviridae Species 0.000 description 1
• 108010059712 Pronase Proteins 0.000 description 1
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
• 241000588769 Proteus <enterobacteria> Species 0.000 description 1
• 241000588770 Proteus mirabilis Species 0.000 description 1
• 101710130181 Protochlorophyllide reductase A, chloroplastic Proteins 0.000 description 1
• 101710138718 Protochlorophyllide reductase B, chloroplastic Proteins 0.000 description 1
• 241000125945 Protoparvovirus Species 0.000 description 1
• 241000589516 Pseudomonas Species 0.000 description 1
• 241000711798 Rabies lyssavirus Species 0.000 description 1
• 241000702247 Reoviridae Species 0.000 description 1
• 241000702263 Reovirus sp. Species 0.000 description 1
• 241001068263 Replication competent viruses Species 0.000 description 1
• 201000000582 Retinoblastoma Diseases 0.000 description 1
• 108700025701 Retinoblastoma Genes Proteins 0.000 description 1
• 108050002653 Retinoblastoma protein Proteins 0.000 description 1
• 241000712907 Retroviridae Species 0.000 description 1
• 241000711931 Rhabdoviridae Species 0.000 description 1
• 241000235402 Rhizomucor Species 0.000 description 1
• 241000235527 Rhizopus Species 0.000 description 1
• 241000316848 Rhodococcus <scale insect> Species 0.000 description 1
• 241000606701 Rickettsia Species 0.000 description 1
• 208000000705 Rift Valley Fever Diseases 0.000 description 1
• 241000122129 Roseolovirus Species 0.000 description 1
• 241000702670 Rotavirus Species 0.000 description 1
• 241000714474 Rous sarcoma virus Species 0.000 description 1
• 241000710801 Rubivirus Species 0.000 description 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
• 241000293026 Saksenaea Species 0.000 description 1
• 241000607142 Salmonella Species 0.000 description 1
• 241000224003 Sarcocystis Species 0.000 description 1
• 241000509427 Sarcoptes scabiei Species 0.000 description 1
• 241000223598 Scedosporium boydii Species 0.000 description 1
• 241000242683 Schistosoma haematobium Species 0.000 description 1
• 241000242680 Schistosoma mansoni Species 0.000 description 1
• 206010039710 Scleroderma Diseases 0.000 description 1
• 206010070834 Sensitisation Diseases 0.000 description 1
• 241000607720 Serratia Species 0.000 description 1
• 108010034546 Serratia marcescens nuclease Proteins 0.000 description 1
• 241000607768 Shigella Species 0.000 description 1
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
• 241000713311 Simian immunodeficiency virus Species 0.000 description 1
• 241000700584 Simplexvirus Species 0.000 description 1
• 241000710960 Sindbis virus Species 0.000 description 1
• 102220497176 Small vasohibin-binding protein_T47D_mutation Human genes 0.000 description 1
• 238000002105 Southern blotting Methods 0.000 description 1
• 241000605008 Spirillum Species 0.000 description 1
• 241000589973 Spirochaeta Species 0.000 description 1
• 241001149963 Sporothrix schenckii Species 0.000 description 1
• 241000191940 Staphylococcus Species 0.000 description 1
• 108091081024 Start codon Proteins 0.000 description 1
• 241001478878 Streptobacillus Species 0.000 description 1
• 241000194017 Streptococcus Species 0.000 description 1
• 241000193998 Streptococcus pneumoniae Species 0.000 description 1
• 241000193996 Streptococcus pyogenes Species 0.000 description 1
• 241000187747 Streptomyces Species 0.000 description 1
• 241000244177 Strongyloides stercoralis Species 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 241000244159 Taenia saginata Species 0.000 description 1
• 241000244157 Taenia solium Species 0.000 description 1
• 241000223777 Theileria Species 0.000 description 1
• 241000710924 Togaviridae Species 0.000 description 1
• 241000711517 Torovirus Species 0.000 description 1
• 241001112221 Toxicocladosporium hominis Species 0.000 description 1
• 241000223996 Toxoplasma Species 0.000 description 1
• 241000223997 Toxoplasma gondii Species 0.000 description 1
• 108700009124 Transcription Initiation Site Proteins 0.000 description 1
• 102100038313 Transcription factor E2-alpha Human genes 0.000 description 1
• 102000004357 Transferases Human genes 0.000 description 1
• 108090000992 Transferases Proteins 0.000 description 1
• 241000589886 Treponema Species 0.000 description 1
• 241000589884 Treponema pallidum Species 0.000 description 1
• 241000243777 Trichinella spiralis Species 0.000 description 1
• 241000224526 Trichomonas Species 0.000 description 1
• 241000167561 Trichomonas tenax Species 0.000 description 1
• 241000223238 Trichophyton Species 0.000 description 1
• 241000223109 Trypanosoma cruzi Species 0.000 description 1
• 102100035283 Tumor necrosis factor ligand superfamily member 18 Human genes 0.000 description 1
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
• 241000202898 Ureaplasma Species 0.000 description 1
• 241000700618 Vaccinia virus Species 0.000 description 1
• 241000711970 Vesiculovirus Species 0.000 description 1
• 241000607598 Vibrio Species 0.000 description 1
• 206010047505 Visceral leishmaniasis Diseases 0.000 description 1
• 241000244005 Wuchereria bancrofti Species 0.000 description 1
• 108010027570 Xanthine phosphoribosyltransferase Proteins 0.000 description 1
• 208000003152 Yellow Fever Diseases 0.000 description 1
• 241000607734 Yersinia <bacteria> Species 0.000 description 1
• MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
• 241000222126 [Candida] glabrata Species 0.000 description 1
• 239000006096 absorbing agent Substances 0.000 description 1
• 238000010521 absorption reaction Methods 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• FMYKJLXRRQTBOR-BZSNNMDCSA-N acetylleucyl-leucyl-norleucinal Chemical compound CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O FMYKJLXRRQTBOR-BZSNNMDCSA-N 0.000 description 1
• 108010091545 acetylleucyl-leucyl-norleucinal Proteins 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 238000007818 agglutination assay Methods 0.000 description 1
• VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
• 229940126575 aminoglycoside Drugs 0.000 description 1
• 230000003321 amplification Effects 0.000 description 1
• 230000000340 anti-metabolite Effects 0.000 description 1
• 239000012984 antibiotic solution Substances 0.000 description 1
• 229940100197 antimetabolite Drugs 0.000 description 1
• 239000002256 antimetabolite Substances 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 230000001174 ascending effect Effects 0.000 description 1
• 244000309743 astrovirus Species 0.000 description 1
• 201000005000 autoimmune gastritis Diseases 0.000 description 1
• 210000003719 b-lymphocyte Anatomy 0.000 description 1
• 201000008680 babesiosis Diseases 0.000 description 1
• 230000004888 barrier function Effects 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• 230000003115 biocidal effect Effects 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 210000001185 bone marrow Anatomy 0.000 description 1
• 210000004556 brain Anatomy 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 210000000621 bronchi Anatomy 0.000 description 1
• AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 108010044208 calpastatin Proteins 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• 238000005341 cation exchange Methods 0.000 description 1
• 150000001768 cations Chemical class 0.000 description 1
• 230000020411 cell activation Effects 0.000 description 1
• 238000012832 cell culture technique Methods 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 230000007541 cellular toxicity Effects 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 239000000919 ceramic Substances 0.000 description 1
• 210000003679 cervix uteri Anatomy 0.000 description 1
• 239000013043 chemical agent Substances 0.000 description 1
• 239000003638 chemical reducing agent Substances 0.000 description 1
• 239000003795 chemical substances by application Substances 0.000 description 1
• 239000012501 chromatography medium Substances 0.000 description 1
• 239000012539 chromatography resin Substances 0.000 description 1
• 208000025302 chronic primary adrenal insufficiency Diseases 0.000 description 1
• 210000001728 clone cell Anatomy 0.000 description 1
• 239000013599 cloning vector Substances 0.000 description 1
• 238000012761 co-transfection Methods 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 210000001072 colon Anatomy 0.000 description 1
• 238000010961 commercial manufacture process Methods 0.000 description 1
• 238000012875 competitive assay Methods 0.000 description 1
• 230000002860 competitive effect Effects 0.000 description 1
• 239000002299 complementary DNA Substances 0.000 description 1
• 239000000356 contaminant Substances 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 239000000599 controlled substance Substances 0.000 description 1
• 238000011968 cross flow microfiltration Methods 0.000 description 1
• 238000009295 crossflow filtration Methods 0.000 description 1
• 208000030381 cutaneous melanoma Diseases 0.000 description 1
• 102000003675 cytokine receptors Human genes 0.000 description 1
• 108010057085 cytokine receptors Proteins 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 239000008121 dextrose Substances 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 238000010586 diagram Methods 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• 230000003292 diminished effect Effects 0.000 description 1
• 235000021186 dishes Nutrition 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• 231100000673 dose–response relationship Toxicity 0.000 description 1
• 229940126534 drug product Drugs 0.000 description 1
• 239000000428 dust Substances 0.000 description 1
• 230000000531 effect on virus Effects 0.000 description 1
• 238000001962 electrophoresis Methods 0.000 description 1
• 230000008030 elimination Effects 0.000 description 1
• 238000003379 elimination reaction Methods 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 206010014599 encephalitis Diseases 0.000 description 1
• 210000002889 endothelial cell Anatomy 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 229940007078 entamoeba histolytica Drugs 0.000 description 1
• 238000001976 enzyme digestion Methods 0.000 description 1
• 210000003979 eosinophil Anatomy 0.000 description 1
• 210000002615 epidermis Anatomy 0.000 description 1
• 210000003238 esophagus Anatomy 0.000 description 1
• ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
• 229960005542 ethidium bromide Drugs 0.000 description 1
• 239000013613 expression plasmid Substances 0.000 description 1
• 210000004700 fetal blood Anatomy 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• 229940126864 fibroblast growth factor Drugs 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 235000013312 flour Nutrition 0.000 description 1
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
• 238000002073 fluorescence micrograph Methods 0.000 description 1
• 235000013305 food Nutrition 0.000 description 1
• 238000013467 fragmentation Methods 0.000 description 1
• 238000006062 fragmentation reaction Methods 0.000 description 1
• 239000012737 fresh medium Substances 0.000 description 1
• 238000002825 functional assay Methods 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 210000000232 gallbladder Anatomy 0.000 description 1
• 238000001502 gel electrophoresis Methods 0.000 description 1
• 238000012817 gel-diffusion technique Methods 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 238000002523 gelfiltration Methods 0.000 description 1
• 238000001476 gene delivery Methods 0.000 description 1
• 230000030279 gene silencing Effects 0.000 description 1
• 230000002068 genetic effect Effects 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 238000011331 genomic analysis Methods 0.000 description 1
• 229940085435 giardia lamblia Drugs 0.000 description 1
• 150000004676 glycans Chemical class 0.000 description 1
• YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
• SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
• YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 1
• 210000003714 granulocyte Anatomy 0.000 description 1
• 230000003394 haemopoietic effect Effects 0.000 description 1
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
• 210000003494 hepatocyte Anatomy 0.000 description 1
• 238000000265 homogenisation Methods 0.000 description 1
• 102000044787 human EP300 Human genes 0.000 description 1
• WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
• 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
• 210000001822 immobilized cell Anatomy 0.000 description 1
• 238000003119 immunoblot Methods 0.000 description 1
• 230000000951 immunodiffusion Effects 0.000 description 1
• 238000000760 immunoelectrophoresis Methods 0.000 description 1
• 102000018358 immunoglobulin Human genes 0.000 description 1
• 239000000367 immunologic factor Substances 0.000 description 1
• 239000003547 immunosorbent Substances 0.000 description 1
• 238000012744 immunostaining Methods 0.000 description 1
• 208000037797 influenza A Diseases 0.000 description 1
• 208000037798 influenza B Diseases 0.000 description 1
• 208000037799 influenza C Diseases 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 239000002054 inoculum Substances 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 229940047122 interleukins Drugs 0.000 description 1
• 210000004347 intestinal mucosa Anatomy 0.000 description 1
• 238000007912 intraperitoneal administration Methods 0.000 description 1
• 238000005342 ion exchange Methods 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 230000002427 irreversible effect Effects 0.000 description 1
• 238000001155 isoelectric focusing Methods 0.000 description 1
• 210000002510 keratinocyte Anatomy 0.000 description 1
• 210000003734 kidney Anatomy 0.000 description 1
• 210000003292 kidney cell Anatomy 0.000 description 1
• 210000000867 larynx Anatomy 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 210000000088 lip Anatomy 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 101150079178 log gene Proteins 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 239000007937 lozenge Substances 0.000 description 1
• 238000003670 luciferase enzyme activity assay Methods 0.000 description 1
• 201000005296 lung carcinoma Diseases 0.000 description 1
• 206010025135 lupus erythematosus Diseases 0.000 description 1
• 239000012139 lysis buffer Substances 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
• 239000001095 magnesium carbonate Substances 0.000 description 1
• 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 201000004792 malaria Diseases 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 238000013507 mapping Methods 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 210000003593 megakaryocyte Anatomy 0.000 description 1
• 229960000485 methotrexate Drugs 0.000 description 1
• 229920000609 methyl cellulose Polymers 0.000 description 1
• 239000001923 methylcellulose Substances 0.000 description 1
• HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 1
• 210000003470 mitochondria Anatomy 0.000 description 1
• 210000001616 monocyte Anatomy 0.000 description 1
• 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
• 210000002200 mouth mucosa Anatomy 0.000 description 1
• 201000006417 multiple sclerosis Diseases 0.000 description 1
• 210000000663 muscle cell Anatomy 0.000 description 1
• 238000002703 mutagenesis Methods 0.000 description 1
• 231100000350 mutagenesis Toxicity 0.000 description 1
• 108700021654 myb Genes Proteins 0.000 description 1
• 229960000951 mycophenolic acid Drugs 0.000 description 1
• HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
• 201000000050 myeloid neoplasm Diseases 0.000 description 1
• 210000001989 nasopharynx Anatomy 0.000 description 1
• 239000006199 nebulizer Substances 0.000 description 1
• 230000001613 neoplastic effect Effects 0.000 description 1
• 210000000653 nervous system Anatomy 0.000 description 1
• 210000000440 neutrophil Anatomy 0.000 description 1
• 230000036963 noncompetitive effect Effects 0.000 description 1
• 238000003199 nucleic acid amplification method Methods 0.000 description 1
• 238000010915 one-step procedure Methods 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 210000003463 organelle Anatomy 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 239000006174 pH buffer Substances 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 238000004810 partition chromatography Methods 0.000 description 1
• 229940051027 pasteurella multocida Drugs 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
• 210000005259 peripheral blood Anatomy 0.000 description 1
• 239000011886 peripheral blood Substances 0.000 description 1
• 229940124531 pharmaceutical excipient Drugs 0.000 description 1
• 239000000825 pharmaceutical preparation Substances 0.000 description 1
• 210000003800 pharynx Anatomy 0.000 description 1
• 229910052698 phosphorus Inorganic materials 0.000 description 1
• 239000011574 phosphorus Substances 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 229920001993 poloxamer 188 Polymers 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 239000011148 porous material Substances 0.000 description 1
• 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
• 230000001323 posttranslational effect Effects 0.000 description 1
• 239000000843 powder Substances 0.000 description 1
• 230000002028 premature Effects 0.000 description 1
• 230000001855 preneoplastic effect Effects 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
• 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 239000003531 protein hydrolysate Substances 0.000 description 1
• 238000001742 protein purification Methods 0.000 description 1
• 210000003689 pubic bone Anatomy 0.000 description 1
• 230000002685 pulmonary effect Effects 0.000 description 1
• 238000003127 radioimmunoassay Methods 0.000 description 1
• ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
• 238000011084 recovery Methods 0.000 description 1
• 210000000664 rectum Anatomy 0.000 description 1
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
• 102000037983 regulatory factors Human genes 0.000 description 1
• 108091008025 regulatory factors Proteins 0.000 description 1
• 239000011347 resin Substances 0.000 description 1
• 229920005989 resin Polymers 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 206010039073 rheumatoid arthritis Diseases 0.000 description 1
• 235000009566 rice Nutrition 0.000 description 1
• CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
• 150000003839 salts Chemical class 0.000 description 1
• 239000012723 sample buffer Substances 0.000 description 1
• 238000007790 scraping Methods 0.000 description 1
• 238000004062 sedimentation Methods 0.000 description 1
• 239000006152 selective media Substances 0.000 description 1
• 230000008313 sensitization Effects 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 239000000741 silica gel Substances 0.000 description 1
• 229910002027 silica gel Inorganic materials 0.000 description 1
• 229960002930 sirolimus Drugs 0.000 description 1
• QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
• 235000020183 skimmed milk Nutrition 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
• 229940054269 sodium pyruvate Drugs 0.000 description 1
• 238000010186 staining Methods 0.000 description 1
• 239000007858 starting material Substances 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• 239000000758 substrate Substances 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 230000008093 supporting effect Effects 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 238000013268 sustained release Methods 0.000 description 1
• 239000012730 sustained-release form Substances 0.000 description 1
• 229920001059 synthetic polymer Polymers 0.000 description 1
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• 210000001760 tenon capsule Anatomy 0.000 description 1
• 210000001550 testis Anatomy 0.000 description 1
• 238000010257 thawing Methods 0.000 description 1
• 230000001225 therapeutic effect Effects 0.000 description 1
• 210000001685 thyroid gland Anatomy 0.000 description 1
• 238000004448 titration Methods 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 108091006106 transcriptional activators Proteins 0.000 description 1
• 108091006107 transcriptional repressors Proteins 0.000 description 1
• 238000011426 transformation method Methods 0.000 description 1
• 229940096911 trichinella spiralis Drugs 0.000 description 1
• 230000010415 tropism Effects 0.000 description 1
• 238000000108 ultra-filtration Methods 0.000 description 1
• 241000701447 unidentified baculovirus Species 0.000 description 1
• 210000003932 urinary bladder Anatomy 0.000 description 1
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
• 210000004291 uterus Anatomy 0.000 description 1
• 239000012808 vapor phase Substances 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1